Copaxone: EU Commission informs Teva over breaching EU antitrust rules
Brussels, 10 October 2022 The European Commission has informed Teva of its preliminary view that...
Antitrust: EU Commission opens formal investigation into possible anticompetitive conduct of Teva in relation to a blockbuster multiple sclerosis medicine
The European Commission has opened a formal antitrust investigation to assess whether the pharmaceutical company...